C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/25/2004	US20040235089 denaturing genetically engineered growth hormones, interferons, interleukins, immunogens or lymphokines obtained from host cells, using solutions of mercapto-organic solvents and urea, then renaturing using buffers, buffer to obtain protein in it's bioactive form
11/25/2004	US20040235073 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235064 Peptide complexes comprising reporter fusion which associate through combinations of helical domains to form an antiparallel leucine zipper; protein-protein interaction assays; mimetics
11/25/2004	US20040235060 Biosensor for defecting chemical agents
11/25/2004	US20040235058 ULBP antibodies
11/25/2004	US20040235050 Method for immobilization of polypeptides
11/25/2004	US20040235041 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
11/25/2004	US20040235040 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
11/25/2004	US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004	US20040235037 Polymorphic markers of prostate carcinoma tumor antigen -1(PCTA-1)
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040235011 Production of multimeric proteins
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234998 Proteins
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234990 Method of screening alzheimer's disease-associated gene
11/25/2004	US20040234982 Human ugrp (uteroglobin-related protein) 1 promoter and its use
11/25/2004	US20040234980 Identifying polymorphisms in bactericidal/permeability-increasing protein gene sequences and using them as diagnostic indicators of enhanced disease resistance in animals
11/25/2004	US20040234979 Differentiall-expressed and up-regulated polynucleotides and polypeptides in breast cancer
11/25/2004	US20040234978 Novel potential-dependent cation channel protein
11/25/2004	US20040234976 Comprises nucleotide sequences coding aspartyl protease for use in identifying modulators for treatment and prevention of nervous system disorders
11/25/2004	US20040234968 Comprises nucleotide sequences coding polypeptides associated with biosynthesis of terpenoid essential oils; for use in transformation and propagation of plants with enhanced peppermint oil production; bioreactors and scent production
11/25/2004	US20040234965 Novel pathways involved in epigenetic memory
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234956 Using transgenic cell expressing viral infectivity factor and cytidine deaminase as tools in identifying modulators of viral infection; viricides; peptide mimetics; enzyme inhibitors
11/25/2004	US20040234953 Viral nucleotide sequences coding envelope proteins for use in preparing antibodies for prevention and treatment of autoimmune disorders
11/25/2004	US20040234951 Chimeric chains that coding for proteins that induce effects directed against viruses
11/25/2004	US20040234949 Infectious bursal disease virus capsid/envelope protein for use in developing vaccine for prevention and treatment of viral infection of chickens; veterinary medicine; immunotherapy
11/25/2004	US20040234617 Water extraction; centrifuging; separation; cooling; freeze drying; hypotensive agents
11/25/2004	US20040234609 Repeat sequence protein polymer active agent congjugates, methods and uses
11/25/2004	US20040234554 Hepatitis B virus crosslinked with immunogens, epitopes; capsid peptide binding to core protein; vaccine
11/25/2004	US20040234553 Cold-adapted equine influenza viruses
11/25/2004	US20040234552 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine
11/25/2004	US20040234542 Immunoassay; open reading frame protein; detecting antibodies
11/25/2004	US20040234541 Diagnosis, therapy cancer; human leukocyte antigen
11/25/2004	US20040234540 An antibody or antibody fragment having specific binding affinity to an ALK-7 polypeptide or an ALK-7 domain polypeptide and a hybridoma which produces the antibody
11/25/2004	US20040234538 Genetic engineered polypeptide; induce immunology response
11/25/2004	US20040234537 Quantitative, qualitative analysis of peptide; monitoring concentration in human tissue of monoclonal antibody; calibration
11/25/2004	US20040234536 Polypeptide containing antigen segment; mixture with antibodies; immunostimulants
11/25/2004	US20040234531 Autoimmune disease; antidiabetic agents; protein
11/25/2004	US20040234530 Plasmid-specific polypeptide found in Eschericha; diagnosis of infections; induction of immunology response
11/25/2004	US20040234529 Helicobacter pylori adhesin binding group antigen
11/25/2004	US20040234527 Peptides for use as translocation factors
11/25/2004	US20040234526 Use of a compound antagonist of esm-1 protein for producing a medicine for treating cancer
11/25/2004	US20040234525 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction
11/25/2004	US20040234524 Anti-osteopontin antibody and use thereof
11/25/2004	US20040234523 Antiischemic agents; synergistic mixture of interleukin inhibitor and tumor necrosis factor antagonist
11/25/2004	US20040234522 therapy, diagnosis of immunology diseases; response to antigenic stimulants; cell differentiation of lymphocytes
11/25/2004	US20040234516 Production of lysosomal enzymes in plants by transient expression
11/25/2004	US20040234515 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor
11/25/2004	US20040234506 Recombinant RSV virus expression systems and vaccines
11/25/2004	US20040234505 Polynucleotide constructs and uses thereof
11/25/2004	US20040234503 Materials and methods relating to improved vaccinations strategies
11/25/2004	US20040234499 Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	US20040234312 Bit mask generation system
11/25/2004	US20040232205 Lantibiotic
11/25/2004	DE10318496A1 Analyse und Verwendung von PAR 1 Polymorphismen zur Risikoabschätzung für kardiovaskuläre Erkrankungen Analysis and use of PAR 1 polymorphisms on risk assessment for cardiovascular disease
11/25/2004	CA2526911A1 Process of producing a plastid-targeted protein in plant cells
11/25/2004	CA2525870A1 Liver x receptor .alpha. splicing mutant protein, gene thereof and use thereof
11/25/2004	CA2525641A1 Materials and methods for immunizing against fiv infection
11/25/2004	CA2525568A1 Novel peptides that bind to the erythropoietin receptor
11/25/2004	CA2525497A1 Peptides that bind to the erythropoietin receptor
11/25/2004	CA2525464A1 Novel poly(ethylene glycol) modified compounds and uses thereof
11/25/2004	CA2525385A1 Grp94-based compositions and methods of use thereof
11/25/2004	CA2524499A1 Broadening adenovirus tropism
11/25/2004	CA2524456A1 Apo2l (trail) receptor binding peptides and uses thereof
11/25/2004	CA2524403A1 Active variants of the il-18 binding protein and medical uses thereof
11/25/2004	CA2523943A1 Compositions and methods for wt1 specific immunotherapy
11/25/2004	CA2523001A1 Therapeutic use of anti-cs1 antibodies
11/25/2004	CA2522614A1 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry
11/24/2004	EP1480445A2 Bit mask generation system and printer drivers and printing methods incorporating bit masks generated utilising same
11/24/2004	EP1479774A1 Viruses dependent on inducing agents for viral entry into a host cell
11/24/2004	EP1479773A1 Mite galectin
11/24/2004	EP1479772A1 Apoptosis promoter and inhibitor interacting with cgi-94 and method of screening the same
11/24/2004	EP1479771A2 Method to screen phage display libraries with different ligands
11/24/2004	EP1479770A1 Surface expression libraries of randomized peptides
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479761A1 New enterovirus, vaccines, medicaments and diagnostic kits
11/24/2004	EP1479694A2 Intrabodies ScFv with defined framework that is stable in a reducing environment
11/24/2004	EP1479693A1 Egf/egfr complex
11/24/2004	EP1479692A1 Peptides responsive to antibodies against a consensus peptide of the CS4-CFA/I family proteins
11/24/2004	EP1479691A1 Long lasting fusion peptide inhibitors for HIV infection
11/24/2004	EP1479689A1 Peptide complex
11/24/2004	EP1479398A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
11/24/2004	EP1479395A1 Modified factor VII
11/24/2004	EP1478931A2 Binding of pathological forms of prion proteins
11/24/2004	EP1478923A2 Assay for anti-ingap antibodies
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478756A2 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
11/24/2004	EP1478752A2 Human chemokine-13
11/24/2004	EP1478751A2 Avian lysozyme promoter
11/24/2004	EP1478750A2 Gene expression by positive feedback activation of a cell type-specific promoter
11/24/2004	EP1478748A2 Fce fusion proteins for treatment of allergy and asthma
11/24/2004	EP1478747A1 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made therefrom
11/24/2004	EP1478744A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof

1 ... 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 ... 2916